MS is a 31 yo female presenting to your clinic with fever, chills, shortness of breath and cough. She has a history of severe asthma, hypertension, and chronic kidney disease (CrCl 45mL/min). She tests positive for COVID-19 and you are considering oral treatment options since she is at a high risk of progression. Which of the following is false? a. Molnupiravir is contraindicated in patients less than 30 years of age b. Her Paxlovid dose requires renal adjustment given her kidney dysfunction c. Contraception should be used for at least 4 days after the last dose of molnupiravir d. Paxlovid is taken twice daily for 5 days